B
CGEM icon

Braidwell’s Cullinan Oncology CGEM Stock Holding History

Braidwell’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-980,773
Closed -$7.42M – 59
2025
Q1 		$7.42M Sell
980,773
-195,400
-17% -$1.87M 0.26% 53
2024
Q4 		$14.3M Hold
1,176,173
– – 0.42% 58
2024
Q3 		$19.7M Buy
1,176,173
+1,000,000
+568% +$17.7M 0.56% 50
2024
Q2 		$3.07M Sell
176,173
-1,064,692
-86% -$22.7M 0.1% 72
2024
Q1 		$21.1M Hold
1,240,865
– – 0.68% 46
2023
Q4 		$12.6M Sell
1,240,865
-668,000
-35% -$5.92M 0.46% 53
2023
Q3 		$17.3M Hold
1,908,865
– – 0.55% 61
2023
Q2 		$20.5M Buy
+1,908,865
New +$20.3M 0.67% 53

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return